ZENTALIS PHARMACEUTICALS INC. - COMMON STOCK

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 мар 2024 18:00:00 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences

28 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational Updates

27 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals to Participate in the Oppenheimer Healthcare Life Sciences Conference

13 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 фев 2024 17:00:00 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Strengthens Management Team with Key Appointments

25 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 янв 2024 16:49:03 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 дек 2023 17:39:15 Источник Nasdaq GlobeNewswire

Zentalis to Participate in Investor Call Focused on Ovarian Cancer with Gynecologic Oncology Key Opinion Leader Joyce F. Liu, M.D., MPH, Hosted by TD Cowen

09 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates

06 ноя 2023 07:18:31 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 ноя 2023 16:52:14 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 окт 2023 16:27:36 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

06 сен 2023 07:00:01 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 сен 2023 16:37:58 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates

09 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

01 авг 2023 16:28:31 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Appoints Kimberly Freeman as Chief Strategy Officer

01 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Pricing of Underwritten Offering of Common Stock

15 июн 2023 06:01:28 Источник Nasdaq GlobeNewswire

Zentalis Announces Intermittent Azenosertib Monotherapy Dosing Nearly Doubles Efficacy Over Continuous Dosing

06 июн 2023 06:00:00 Источник Nasdaq GlobeNewswire

Zentalis Announces Presentation of Positive Phase 1b Data Demonstrating Durable Responses and Favorable Safety Profile of Azenosertib in Combination with Chemotherapy at the 2023 ASCO Annual Meeting

25 май 2023 17:38:38 Источник Nasdaq GlobeNewswire